| Overall | Males | Females | p value | |||
---|---|---|---|---|---|---|---|
n | Prevalence (95Â % CI) | n | Prevalence (95Â % CI) | n | Prevalence (95Â % CI) | ||
Comorbidity | 203 | 19.6 (17.3–22.2) | 47 | 14.9 (11.1–19.3) | 156 | 21. 8 (18.8–25.0) | 0.010 |
Multi-morbidity | 47 | 4.6 (3.3 6.1) | 9 | 1.8 (1.3–2.3) | 38 | 2.7 (2.4–3.2) | 0.025 |
Hypertension | 106 | 10.2 (8.4–12.3) | 22 | 7.0 (4.4–10.4) | 84 | 11.7 (9.5–14.3) | 0.020 |
T2DM | 22 | 2.1 (1.3–3.2) | 6 | 1.9 (0.7–4.1) | 16 | 2.2 (1.2–3.6) | 0.731 |
Asthma | 45 | 4.3 (3.1–5.8) | 7 | 2.2 (0.9–4.5) | 38 | 5.3 (3.8–7.2) | 0.026 |
Cancer | 19 | 1.8 (1.1–2.8) | 6 | 1.9 (0.7–4.1) | 13 | 1.8 (1.0–3.1) | 0.925 |
Congestive cardiac failure | 16 | 1.5 (0.9–2.5) | 3 | 0.9 (0.2–2.7) | 13 | 1.8 (1.0–3.1) | 0.299 |
Stroke | 10 | 1.0 (0.5–1.8) | 2 | 0.6 (0.08–2.3) | 8 | 1.1 (0.5–2.2) | 0.465 |
Others | 39 | 3.8 (2.7–5.1) | 9 | 2.8 (1.3–5.3) | 30 | 4.2 (2.8–5.9) | 0.297 |